Testing effectiveness (Phase 2)Study completedNCT02009332
What this trial is testing
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer
Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Aadi Bioscience, Inc. 21
Showing 9 of 9 results